Quantitative Proteomics Reveal an Altered Pattern of Protein Expression in Brain Tissue from Mice Lacking GPR37 and GPR37L1

Abstract

GPR37 and GPR37L1 are glia-enriched GPCRs that have been implicated in several neurological and neurodegenerative diseases. To gain insight into the potential molecular mechanisms by which GPR37 and GPR37L1 regulate cellular physiology, proteomic analyses of whole mouse brain tissue from wild-type (WT) versus GPR37/GPR37L1 double knockout (DKO) mice were performed in order to identify proteins regulated by the absence versus presence of these receptors (data are available via ProteomeXchange with identifier PXD015202). These analyses revealed a number of proteins that were significantly increased or decreased by the absence of GPR37 and GPR37L1. One of the most decreased proteins in the DKO versus WT brain tissue was S100A5, a calcium-binding protein, and the reduction of S100A5 expression in KO brain tissue was validated via Western blot. Co-expression of S100A5 with either GPR37 or GPR37L1 in HEK293T cells did not result in any change in S100A5 expression but did robustly increase secretion of S100A5. To dissect the mechanism by which S100A5 secretion was enhanced, cells co-expressing S100A5 with the receptors were treated with different pharmacological reagents. These studies revealed that calcium is essential for the secretion of S100A5 downstream of GPR37 and GPR37L1 signaling, as treatment with BAPTA-AM, an intracellular Ca 2+ chelator, reduced S100A5 secretion from transfected HEK293T cells. Collectively these findings provide a panoramic view of proteomic changes resulting from loss of GPR37 and GPR37L1 and also impart mechanistic insight into the regulation of S100A5 by these receptors, thereby shedding light on the functions of GPR37 and GPR37L1 in brain tissue.

The Effect of Early Life Stress on Emotional Behaviors in GPR37KO Mice

“…GPR37KO embryos on a C57BL/6J genetic background [ 46 , 47 ] were a kind gift from Dr. Randy Hall. Mice were subsequently bred and maintained in the Wallenberg animal facility of Karolinska Institutet.…”

Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target

“…Much of our understanding of GPR37 and GPR37L1, in the absence of a defined ligand, has come from studies utilizing animal models that either overexpress or lack these receptors. ,− A major focus of prior GPR37 research has primarily been related to Parkinson’s disease (PD). PD is a complex neurodegenerative disorder with multifaceted mechanisms contributing to its development, including impaired protein clearance pathways, such as the ubiquitin-proteasome system and autophagy leading to the accumulation of aggregated misfolded proteins called Lewy bodies, the loss of dopamine-producing neurons, an imbalance in oxidative stress response, impaired mitochondrial function, overactive immune cells such as microglia and astrocytes contributing to inflammation and neuronal damage, and certain genetic mutations and variations associated with an increased risk of developing PD .…”

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor

“…Only proteins identified in all three biological replicates in at least one experimental condition (control or under IM/ MK-4440 treatment) were further considered for statistical analysis (totally 3120 proteins in GIST-T1/829 cell line subgroup and 2837 proteins in GIST-T1 subgroup). In order to save normal distribution of the Log 2 -transformed intensity histogram and to simulate signals from low-abundant proteins, the filtered LFQ data were subjected to imputation of missing values performed from the normal distribution (width 0.3 and down shift 1.8) [26]. After normalization, Pearson's correlation was used to identify potential outliers; as a result, there were no replicates removed from the analysis.…”